Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
FOLFIRI+Bevacizumab
DRUG
2 trials
Sponsors
Giammaria Fiorentini
, Fudan University
Conditions
Colorectal Cancer
Liver Metastasis Colon Cancer
Phase 2
Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer
Active, not recruiting
NCT05969899
Fudan University
Colorectal Cancer
Start: 2023-07-10
End: 2027-02-10
Target: 50
Updated: 2024-11-21
Unknown Phase
TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
NCT03732235
Giammaria Fiorentini
Liver Metastasis Colon Cancer
Start: 2018-10-01
End: 2021-12-31
Target: 50
Updated: 2019-02-21
Related Papers
Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases.
2021-07-13
4 citations
Chemoembolization Alone or Associated With Bevacizumab for Therapy of Colorectal Cancer Metastases: Preliminary Results of a Randomized Study
In Vivo
2020-01-01
20 citations